Comparing ischemic cardiovascular effectiveness and safety between individual SGLT-2 inhibitors and DPP-4 inhibitors in patients with type 2 diabetes: a nationwide population-based cohort study
ObjectivesThis study compared the ischemic cardiovascular events (iCVEs) effectiveness and safety of initiating empagliflozin or dapagliflozin with those of dipeptidyl peptidase-4 inhibitors (DPP-4is), as well as the comparative effects between empagliflozin and dapagliflozin.MethodsUsing data from...
Збережено в:
Автори: | , , , , , |
---|---|
Формат: | Книга |
Опубліковано: |
Frontiers Media S.A.,
2024-10-01T00:00:00Z.
|
Предмети: | |
Онлайн доступ: | Connect to this object online. |
Теги: |
Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
Інтернет
Connect to this object online.3rd Floor Main Library
Шифр: |
A1234.567 |
---|---|
Примірник 1 | Доступно |